Featured Article

SCOPE 2024: Steve Young of CluePoints Discusses RBQM and Key Risk Indicators

In an interview with ACT editor Andy Studna at SCOPE, Young, Chief Science Officer, CluePoints discusses where the industry is currently adopting RBQM and the level of comfort that comes with it.

Guide

A Comprehensive Guide to Adaptive Site Monitoring

Download
Blog
RBQM for the Mid-Market Explained
  • Mid-market sponsors are expected to meet the same ICH E6(R3) standards as large pharma, often with...
Read More
Blog
5 Myths Mid-Market Teams Believe About RBQM and What ICH E6(R3) Actually Requires
  • Risk-Based Quality Management (RBQM) is no longer a future-state concept. Under ICH E6(R3), it is a...
Read More
Blog
Modern RBQM Has Evolved. Is Your Organization Ready?
  • Most sponsors and CROs are now fluent in the language of Risk-Based Quality Management (RBQM). Terms...
Read More
CluePoints RBQM Live25 On-Demand Recordings are now Available! Banner - ROI of RBQM, ICH E6(R3) in Practice, Future of AI